
Press releases
16th Jun 2022
NICE to evaluate the Genedrive® MT-RNR1 Test under their Diagnostics Assessment Programme
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the UK...
30th May 2022
Point-of-Care Genedrive® COV19-ID Kit receives Coronavirus Test Device Approval (“CTDA”)
genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the UK...
29th Mar 2022
Interim results to 31 December 2021
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces unaudited i...